Literature DB >> 7842191

Asthma self-management education program by home monitoring of peak expiratory flow.

J M Ignacio-Garcia1, P Gonzalez-Santos.   

Abstract

A prospective controlled trial of home monitoring of peak expiratory flow rate (PEFR) was conducted to determine the usefulness of an objective measure of lung function in association with an education program and a medication self-management plan in reducing morbidity in adult patients with asthma. Thirty-five patients managed themselves, using peak flow readings as the basis for the therapeutic plan coupled with educational intervention, whereas 35 control patients used symptoms and spirometric data for following physicians' treatment plans. After a 6-mo study period, patients in the experimental group showed statistically significant improvements in morbidity parameters (days lost from work, acute asthma attacks, days on antibiotic therapy, physician consultations, and emergency room admissions for asthma), increases in FVC, FEV1, and FEV1/FVC, mean PEFR and mean morning PEFR, decrease in percentage of the mean PEFR amplitude, and a reduction in the use of inhaled beta-agonists, oral theophylline, and oral prednisone. Although improvements in some of these parameters were also found in the control group, they did not reach the levels of significance obtained in the experimental group. The personal use of an objective measure of lung function in association with a medication self-management plan leads to improvement in the patient's condition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7842191     DOI: 10.1164/ajrccm.151.2.7842191

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  23 in total

Review 1.  Written action plans for asthma: an evidence-based review of the key components.

Authors:  P G Gibson; H Powell
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

2.  Asthma guidelines: invited commentaries.

Authors:  T S Hallstrand
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-10

3.  A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma.

Authors:  A Sonia Buist; William M Vollmer; Sandra R Wilson; E Ann Frazier; Arthur D Hayward
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

4.  Action plans in asthma management. Why, when, and how?

Authors:  S Janson
Journal:  West J Med       Date:  1996-09

5.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

Review 6.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

7.  The impact of guidelines on long-term asthma care: a study of hospitalised patients in Malta.

Authors:  Antonella Tonna; Dorothy J McCaig; Joseph M Cacciottolo
Journal:  Pharm World Sci       Date:  2004-08

8.  The Saudi Initiative for Asthma.

Authors:  Mohamed S Al-Moamary; Mohamed S Al-Hajjaj; Majdy M Idrees; Mohamed O Zeitouni; Mohammed O Alanezi; Hamdan H Al-Jahdali; Maha Al Dabbagh
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

9.  A multivariate model for predicting respiratory status in patients with chronic obstructive pulmonary disease.

Authors:  G H Murata; C O Kapsner; D J Lium; H K Busby
Journal:  J Gen Intern Med       Date:  1998-07       Impact factor: 5.128

10.  A randomised trial of self-management planning for adult patients admitted to hospital with acute asthma.

Authors:  L M Osman; C Calder; D J Godden; J A R Friend; L McKenzie; J S Legge; J G Douglas
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.